
Gilead Sciences
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.
Gilead to Acquire Tubulis Adding Potentially Best in Class Antibody ...
Apr 7, 2026 · FOSTER CITY, Calif. & MUNICH-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has entered into a definitive agreement to acquire Tubulis GmbH, a private …
Gilead Sciences: Company
Learn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information.
Gilead Sciences, Inc. - Gilead Sciences to Acquire Arcellx to Maximize ...
Feb 23, 2026 · Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif. Forward-Looking Statements This communication contains forward-looking statements related …
Careers at Gilead Sciences
Gilead, a global biopharma co. pursuing innovation in virology, oncology and inflammation, offers a variety of career opportunities in an inclusive workplace where all can make an impact.
Gilead Sciences, Inc. - Gilead to Acquire Tubulis Adding Potentially ...
Apr 7, 2026 · FOSTER CITY, Calif. & MUNICH-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has entered into a definitive agreement to acquire Tubulis GmbH, a private …
Gilead Sciences, Inc. - Gilead Sciences Announces Fourth Quarter and ...
Feb 10, 2026 · FOSTER CITY, Calif.-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025. “Our fourth quarter …
Virology, Inflammation, & Oncology Pipeline | Gilead
Feb 12, 2026 · Through science and innovative partnerships, Gilead expands research and development programs in virology, oncology, & inflammation. Learn about our pipeline.
Gilead Sciences Medicines
Gilead is committed to helping improve the lives of people around the world by bringing forward medicines that prevent, treat and cure devastating diseases.
Newsroom | Gilead
Visit Gilead's media page to view news releases.